View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Solid Form Solutions
12 April 2010

Solid Form Solutions Launches New Custom Synthesis Service

Solid Form Solutions is pleased to unveil its custom synthesis service to complement its solid form screening programmes. Using a ‘quality by design’ approach, the integration of the two services provides a powerful and rapid low-risk route to manufacture.

Our experienced synthetic chemistry team are capable of locating the first route to a drug molecule and delivering a scaled-up, optimised process. Our capabilities include:

  • Contract organic synthesis
  • Custom organic synthesis (no product, no fee)
  • Specialists in polymer, macromolecule and peptide synthesis
  • Synthesis of novel compounds and intermediates
  • Expansion of molecular libraries
  • Hit to lead optimisation
  • Extensive analytical support and services

Our specialised equipment capability includes:

  • Impurity isolation and identification
  • High-field NMR 1H, 13C, N and 31P nuclei (including 2D NMR for full structure elucidation)
  • Mass spectrometry (EI, CI, ESI and MALDI)
  • HPLC (method development)

Whether our synthetic work programmes are used separately, or in tandem with a screening activity, SFS will deliver the most efficient synthetic chemistry.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena